AstraZeneca scraps late-stage lung cancer trial after data setback

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 3 hours ago

Holtec Nuclear suspends planned US IPO

Investing.com

stocksabout 3 hours ago

Snap targets enterprises with Salesforce, Nvidia AI tools for augmented-reality glasses

Investing.com

stocksabout 4 hours ago

Exxon advances talks to return to Venezuela’s Orinoco Belt, sources say

Investing.com